116 related articles for article (PubMed ID: 7936303)
1. Radiosensitization with carotid intra-arterial bromodeoxyuridine +/- 5-fluorouracil biomodulation for malignant gliomas.
Greenberg HS; Chandler WF; Ensminger WD; Sandler H; Junck L; Page MA; Crane D; McKeever P; Tankanow R; Bromberg J
Neurology; 1994 Sep; 44(9):1715-20. PubMed ID: 7936303
[TBL] [Abstract][Full Text] [Related]
2. Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas.
Greenberg HS; Chandler WF; Diaz RF; Ensminger WD; Junck L; Page MA; Gebarski SS; McKeever P; Hood TW; Stetson PL
J Neurosurg; 1988 Oct; 69(4):500-5. PubMed ID: 3047341
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.
Hegarty TJ; Thornton AF; Diaz RF; Chandler WF; Ensminger WD; Junck L; Page MA; Gebarski SS; Hood TW; Stetson PL
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):421-8. PubMed ID: 2168357
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial 5-bromo-2-deoxyuridine (BUdR) radiosensitization with external beam radiation in rhesus monkeys: toxicity study.
Greenberg HS; Chandler WF; Diaz RF; Averill DR; Gebarski SS; Lichter AS; Ensminger WD
J Neurooncol; 1988 Dec; 6(4):349-54. PubMed ID: 3221261
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial of intravenous infusion of bromodeoxyuridine (BUdR) for radiosensitization of malignant brain tumors.
Matsutani M; Kohno T; Nagashima T; Nagayama I; Matsuda T; Hoshino T; Sano K
Radiat Med; 1988; 6(1):33-9. PubMed ID: 3045898
[TBL] [Abstract][Full Text] [Related]
6. Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: a phase I and drug incorporation study.
Eisbruch A; Robertson JM; Johnston CM; Tworek J; Reynolds KR; Roberts JA; Lawrence TS
J Clin Oncol; 1999 Jan; 17(1):31-40. PubMed ID: 10458215
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.
Phuphanich S; Levin EM; Levin VA
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1769-72. PubMed ID: 6480461
[TBL] [Abstract][Full Text] [Related]
8. The clinical rationale for S-phase radiosensitization in human tumors.
McGinn CJ; Kinsella TJ
Curr Probl Cancer; 1993; 17(5):273-321. PubMed ID: 8281809
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR).
Mitchell JB; Kinsella TJ; Russo A; McPherson S; Rowland J; Smith BH; Kornblith PL; Glatstein E
Int J Radiat Oncol Biol Phys; 1983 Apr; 9(4):457-63. PubMed ID: 6303991
[TBL] [Abstract][Full Text] [Related]
10. A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.
Kinsella TJ; Russo A; Mitchell JB; Rowland J; Jenkins J; Schwade J; Myers CE; Collins JM; Speyer J; Kornblith P
Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):69-76. PubMed ID: 6321412
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of malignant gliomas: studies of the BTCG.
Shapiro WR
Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662
[TBL] [Abstract][Full Text] [Related]
12. Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer.
Kinsella TJ; Mitchell JB; Russo A; Aiken M; Morstyn G; Hsu SM; Rowland J; Glatstein E
J Clin Oncol; 1984 Oct; 2(10):1144-50. PubMed ID: 6092551
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization of malignant brain tumours with bromouridine (thymidine analogue).
Hoshino T; Sano K
Acta Radiol Ther Phys Biol; 1969; 8(1-2):15-26. PubMed ID: 5800876
[No Abstract] [Full Text] [Related]
14. [Result of combined therapy of maxillary sinus carcinoma with intra-arterial infusion of BUdR-5 FU and radiation (author's transl)].
Sakai S; Shigematzu Y; Fuchihata H; Tanaka Y; Ozaki M
Nihon Gan Chiryo Gakkai Shi; 1978 Oct; 13(5):529-36. PubMed ID: 722139
[No Abstract] [Full Text] [Related]
15. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257
[TBL] [Abstract][Full Text] [Related]
16. Mucocutaneous complications of intraarterial 5-bromodeoxyuridine and radiation.
McCuaig CC; Ellis CN; Greenberg HS; Hegarty TJ; Page MA
J Am Acad Dermatol; 1989 Dec; 21(6):1235-40. PubMed ID: 2584461
[TBL] [Abstract][Full Text] [Related]
17. Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy.
Li Y; Owusu A; Lehnert S
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):519-27. PubMed ID: 14751523
[TBL] [Abstract][Full Text] [Related]
18. The ocular effects of intracarotid bromodeoxyuridine and radiation therapy in the treatment of malignant glioma.
Vander JF; Kincaid MC; Hegarty TJ; Page M; Averill D; Junck L; Greenberg HS
Ophthalmology; 1990 Mar; 97(3):352-7. PubMed ID: 2186331
[TBL] [Abstract][Full Text] [Related]
19. [Continuous superselective intra-arterial infusion with BUdR and 5 FU in combination with radiotherapy in the treatment of head and neck tumors].
Hattori T; Tashiro T; Toyota S; Hirano T; Nakagawa T; Yamaguchi N; Sakakura Y; Murata M
Gan No Rinsho; 1988 Oct; 34(13):1893-902. PubMed ID: 3199521
[TBL] [Abstract][Full Text] [Related]
20. [A trial of ACNU and radiation therapy with sensitizing agents for malignant gliomas].
Kawano H; Hayashi M; Satoh K; Ishii H; Nakatsugawa S; Ishii Y
No To Shinkei; 1989 Nov; 41(11):1071-5. PubMed ID: 2620008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
